Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Ironvine Capital Partners. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
Annualized+11.14%
Positioning StanceConstructive
GeographyUS
Digest Analysis
Quick Take
"Ironvine exited JPMorgan after nine years due to banking sector regulatory uncertainty following Silicon Valley Bank's collapse. The manager identified systemic duration mismatch risks across banks and expects increased regulation."
Executive Summary
Ironvine sold its nine-year JPMorgan Chase position during Q1 2023, generating a 17% IRR, due to concerns about regulatory backlash following the banking crisis. The manager analyzed Silicon Valley Bank's collapse as a case study in poor asset-liability management, where the bank invested $85 billion in long-duration mortgage-backed securities at 1.6% yields using short-term deposits. When rates rose sharply, unrealized losses exceeded the bank's equity, leading to its failure. The manager believes similar duration mismatches exist across the banking sector, creating systemic risk. Proceeds from JPM were reinvested into businesses with higher returns on equity without leverage requirements. Thermo Fisher Scientific remains a major holding, valued for management's capital allocation skills and dominant market positions. The company's recurring revenue model and secular growth exposure to biopharma markets provide attractive long-term prospects despite near-term Covid revenue headwinds.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
72%
Market Conviction
High conviction demonstrated through decisive JPM exit after nine-year hold and detailed analysis of banking sector risks. Manager names specific positions, discusses sizing (TMO as 'largest investment'), and provides clear investment rationale with specific return expectations.
38%
Growth Outlook
Manager expresses caution about banking sector systemic risks and regulatory uncertainty, but maintains constructive view on high-quality businesses outside banking. The tone is selective rather than broadly bearish.
55%
Risk Appetite
Portfolio positioning shows selective risk-taking with exit from banking sector but continued investment in quality businesses. Manager is rotating capital rather than de-risking broadly.
5%
Capital Deployment
Manager rotated capital from JPM sale into other businesses but no indication of net cash level changes. This represents portfolio rotation rather than net deployment or de-risking.
50%
Forward Guidance
Manager indicates selective deployment approach, moving capital from regulated sectors to businesses with better return profiles. No clear bias toward aggressive deployment or defensive positioning.
45%
Language Signal
Language contains significant risk discussion around banking sector and regulatory concerns, balanced by positive commentary on capital allocation and business quality in other sectors.
68%
Perceived Risk
Manager identifies specific systemic risks in banking sector including duration mismatch, unrealized losses, and regulatory backlash. Detailed discussion of multiple risk scenarios and potential for additional bank failures.
55%
Opportunity Density
Manager found attractive reinvestment opportunities for JPM proceeds in businesses with better return profiles, suggesting selective but available opportunities outside the banking sector.
75%
Time Horizon
Manager demonstrates long-term orientation with nine-year JPM holding period and multi-year outlook for TMO. Discussion of 'long into the future' earnings power and willingness to hold through cycles indicates patient capital approach.